Cabozantinib with nivolumab for untreated advanced renal cell carcinoma

Evaluation committee members

The 4 technology appraisal committees are standing advisory committees of NICE. This topic was considered by committee B. Committee members from committee A, committee C and committee D also took part in the meeting.

Committee members are asked to declare any interests in the technology being evaluated. If it is considered there is a conflict of interest, the member is excluded from participating further in that evaluation.

The minutes of each evaluation committee meeting, which include the names of the members who attended and their declarations of interests, are posted on the NICE website.

Chair

Charles Crawley
Chair, technology appraisal committee B

NICE project team

Each evaluation is assigned to a team consisting of 1 or more health technology analysts (who act as technical leads for the evaluation), a technical adviser and a project manager.

Lewis Ralph
Technical lead

Christian Griffiths
Technical adviser

Jeremy Powell
Project manager